Search details
1.
Safety and effectiveness of three novel all-oral shortened regimens for rifampicin- or multidrug-resistant tuberculosis in Kazakhstan.
Clin Infect Dis
; 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38833593
2.
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs.
Clin Infect Dis
; 75(8): 1307-1314, 2022 10 12.
Article
in English
| MEDLINE | ID: mdl-35243494
Results
1 -
2
de 2
1
Next >
>>